Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-03-31): -0.04.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.03
EARNINGS PER SHARE (EPS) AVG 3Y
0.05
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cellyan Biotechnology Co., Ltd
Market Cap
$1.10M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.03
3Y Avg
0.05
5Y Avg
N/A
Market Cap
$1.07M
Earnings Per Share (EPS)
-89.20
TTM Avg
-39.24
3Y Avg
-1704.73
5Y Avg
-1696.36
Market Cap
$1.20M
Earnings Per Share (EPS)
-19.33
TTM Avg
-12.55
3Y Avg
-11.71
5Y Avg
-15.69
Market Cap
$1.15M
Earnings Per Share (EPS)
N/A
TTM Avg
-76.17
3Y Avg
-936.34
5Y Avg
-837.30
Market Cap
$1.18M
Earnings Per Share (EPS)
-25.63
TTM Avg
-194.44
3Y Avg
-204405.59
5Y Avg
-4804085.69
Market Cap
$1.03M
Earnings Per Share (EPS)
-8.02
TTM Avg
-25.27
3Y Avg
-9.38
5Y Avg
-7.51
Market Cap
$873327.00
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.74
3Y Avg
-18.16
5Y Avg
-24.28
Market Cap
$877957.00
Earnings Per Share (EPS)
-180.45
TTM Avg
-617.40
3Y Avg
-559.80
5Y Avg
-483.70
Market Cap
$861788.00
Earnings Per Share (EPS)
-29.09
TTM Avg
-56.46
3Y Avg
-589.82
5Y Avg
-783.52
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.10M | N/A | -0.03 | 0.05 | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | -89.20 | -39.24 | -1704.73 | -1696.36 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.20M | -19.33 | -12.55 | -11.71 | -15.69 |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | N/A | -76.17 | -936.34 | -837.30 |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.18M | -25.63 | -194.44 | -204405.59 | -4804085.69 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -8.02 | -25.27 | -9.38 | -7.51 |
| Bone Biologics Corporation (BBLG)vs › | $873327.00 | -1.86 | -3.74 | -18.16 | -24.28 |
| GlucoTrack, Inc. (GCTK)vs › | $877957.00 | -180.45 | -617.40 | -559.80 | -483.70 |
| Decoy Therapeutics Inc. (DCOY)vs › | $861788.00 | -29.09 | -56.46 | -589.82 | -783.52 |
| Genprex, Inc. (GNPX)vs › | $1.37M | -158.78 | -3127.89 | -13218.44 | -15729.46 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -0.05 |
| 2025-03-31 | 0.00 |
| 2024-03-31 | 0.18 |
| 2023-03-31 | 0.09 |
